Scotiabank Raises Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $21.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price raised by investment analysts at Scotiabank from $20.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s target price suggests a potential upside of 2.84% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. Wells Fargo & Company boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th. Citigroup raised their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Finally, UBS Group boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, February 19th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $21.80.

Sabra Healthcare REIT Trading Down 0.7%

Shares of SBRA opened at $20.42 on Monday. The company’s fifty day simple moving average is $19.39 and its 200-day simple moving average is $18.94. The company has a market cap of $5.15 billion, a P/E ratio of 31.91, a P/E/G ratio of 1.65 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT has a twelve month low of $15.75 and a twelve month high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts expect that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds have recently modified their holdings of the business. Rothschild Investment LLC boosted its stake in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares in the last quarter. Founders Capital Management bought a new stake in Sabra Healthcare REIT during the 3rd quarter valued at $28,000. Strengthening Families & Communities LLC purchased a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at $29,000. Finally, Danske Bank A S bought a new position in shares of Sabra Healthcare REIT in the 3rd quarter worth $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.